1.3.1.1	5-chloro-2,4-dihydroxypyridine	potent inhibitor	143670	
1.3.1.1	cisplatin	cell lines CAL 27, CAL 33, CAL 51, PANC 3	1397	
1.3.1.1	dipyridamole	cell lines CAL 27, CAL 33, CAL 51, ORL 1, PANC 3, mechanism	1192	
1.3.1.1	Hydroxyurea	cell lines CAL 27, CAL 33, CAL 51, ORL 1, PANC 3	850	
1.3.1.1	interferon-alpha-2a	cell lines CAL 27, CAL 33, CAL 51, CAL 7, PANC 3	106314	
1.3.1.1	additional information	combined oral treatment with uracil and tegafur has no influence on DPD activity	2	
1.3.1.1	Uracil	reversible inhibition	334